Horror took 12.1% of US ticket sales in 2025, up from 9.8%. Inside the ROI gap between indie horror and studio blockbusters, and what 2026 changed.Horror is the only major genre currently increasing both its supply of films and its total grosses, while mid-budget production declines everywhere else. That single fact explains most of what is happening to theatrical distribution strategy.
Table of Contents
Through August 2025, horror films accounted for 14.91% of total box office revenue, generating $843.88 million, and the genre’s share of domestic ticket sales rose from 9.8% in 2024 to 12.1% in 2025, according to industry data compilations. In 2023 horror accounted for more than 10% of box office revenue, having doubled its share in a decade.
The efficiency figures are more striking than the share figures. Horror ranked fifth by gross in 2024 at $847 million but generated $16.0 million per film — four times the drama average and 33 times the documentary average — and produced 9.84% of domestic box office from just 7.8% of total releases, per the Screamwire Horror Industry Report.
| Film | Budget | Domestic / worldwide gross | Multiple | Category |
|---|---|---|---|---|
| Terrifier 3 | ~$2m | $51.6m domestic | 43.5x | Micro-budget indie |
| Longlegs | ~$10m | $74.4m domestic | ~7.4x | Indie / specialty |
| M3GAN | $10–20m | $126.9m | 6–12x | Studio genre (Blumhouse model) |
| Weapons | Mid-budget | $269.9m worldwide | — | Studio original, R-rated |
| Sinners | Mid-budget | $370.2m worldwide | — | Studio original, R-rated |
| Final Destination Bloodlines | Franchise | $317.8m worldwide | — | Franchise reboot |
| The Conjuring: Last Rites | Franchise | $499.1m worldwide | — | Established universe |
| Backrooms (2026) | A24 | $394.1m worldwide | — | IP adaptation |
Gross figures compiled from Wikipedia’s horror film records and the all-time list; budget and multiple data from the Screamwire report.
The distribution is bimodal, and that is the important structural point. Micro-budget indie horror delivers extraordinary multiples on small absolute returns. Franchise horror delivers large absolute returns on modest multiples. The squeezed middle — the $40–70 million genre film with no IP and no breakout hook — is where losses concentrate, which is the same squeeze killing mid-budget production across every other genre.
The most commercially significant development was the performance of original R-rated horror. Weapons became the second original R-rated film of the year to reach $100 million domestically after Sinners, at a time when the wider genre was under pressure, according to The Hollywood Reporter. Weapons reached the $100 million North American mark in its fourteenth day against nine days for Sinners, which opened to $48 million, and narrowly bested Jaws on an unadjusted basis to rank as the top-grossing R-rated horror film domestically — though its worldwide tally sat well behind Jaws globally.
Sinners‘ domestic gross of roughly $279.6 million was the largest for a horror film since It reached $328.8 million in 2017.
The year front-loaded unusually. January and February accounted for the overwhelming majority of the genre’s Q1 revenue, buoyed by Scream 7, Send Help, Iron Lung and Primate, before March went quiet outside a few smaller titles, per IndieWire. The publication’s key observation: in 2026, studios are still treating horror as a year-round attraction rather than a seasonal afterthought.
By mid-year, horror had become one of the year’s dominant commercial stories, with Obsession — a Focus Features psychological thriller from Curry Barker — leading the genre and A24’s Backrooms adapting an internet creepypasta into a major release, according to trade roundups.
Performance intensity is a budget line that pays. The commercial argument for immersive, physically demanding performances in genre film is not artistic — it is marketing efficiency. A transformation performance generates earned media, awards-adjacent coverage and word-of-mouth that a $40 million marketing spend would otherwise have to buy. Terrifier 3‘s 43.5x return did not come from advertising; it came from a performance and a reputation that travelled without it.
Horror is countercyclical in a specific way. Its economics do not depend on premium formats, international star recognition or family co-viewing — the three things a contracting theatrical market damages most. That is why horror supply is rising while mid-budget production falls generally.
Franchise universes compound. The Conjuring universe has grossed roughly $2.4 billion worldwide across eight films. Once an established universe exists, each subsequent entry carries lower marketing cost per dollar of gross, which is why studios pursue universe construction over one-off successes even when the one-offs have better multiples.
Streaming is a complement, not a substitute. Shudder set viewership records in 2024, doubling total hours, and horror’s October streaming share reached 15.8%. The genre appears to sustain both theatrical and at-home demand simultaneously, which is not true of most categories.
The gap in most coverage. Analysts consistently report horror’s revenue share without reporting its revenue efficiency. Share is a demand statistic; efficiency is an investment statistic. A genre producing 9.84% of domestic box office from 7.8% of releases is outperforming on a per-slot basis, and that ratio — not the headline share — is what should drive greenlight decisions.
Entertainment investors. The barbell is the actionable structure: micro-budget indie horror for multiple, established franchise horror for absolute return, and nothing in between. The $40–70 million original genre film is the category to avoid.
Film industry observers. Watch whether 2026’s originals replicate 2025’s. The genre’s health currently rests on original R-rated titles performing at franchise levels, which is historically unusual and may not persist.
Distributors. The seasonal assumption is obsolete. January and February carried the majority of Q1 2026 horror revenue, and studios releasing horror year-round are capturing calendar slots that used to be conceded to family and awards product.
Producers. Casting for transformation is a defensible budget allocation in this genre specifically, because the performance itself functions as a marketing asset in a way it does not in most categories.
Horror accounted for 12.1% of US domestic ticket sales in 2025, up from 9.8% in 2024, and 14.91% of total box office revenue through August 2025 on $843.88 million of gross.
On return multiple, yes. Terrifier 3 turned roughly $2 million into $51.6 million domestic — about 43.5x — while franchise titles like The Conjuring: Last Rites deliver far larger absolute grosses at lower multiples.
Among dedicated horror titles, The Conjuring: Last Rites led at $499.1 million worldwide, followed by Sinners at $370.2 million and Final Destination Bloodlines at $317.8 million.
Because the seasonal model left revenue on the table. In 2026, January and February produced the overwhelming majority of Q1 horror revenue, confirming that demand is not confined to autumn.
Anne Carson, the Canadian classicist, poet, essayist, and translator, was awarded the 2026 Nobel Prize…
Polls and primary turnout show Republicans trailing on enthusiasm ahead of the 2026 midterms. Here’s…
Twenty-seven years after its premiere, The West Wing is still being rewatched, argued over, and…
Kianna Underwood was a working child actor who grew up on screen, and her death…
"Min Ah" is one of the most searched names in Korean drama, and it points…
UNITED NATIONS — September 24, 2026: Pakistan has warned the United Nations Security Council that…